Welcome to our dedicated page for Conmed news (Ticker: CNMD), a resource for investors and traders seeking the latest updates and insights on Conmed stock.
Conmed Corporation (CNMD) delivers innovative medical technologies that enhance surgical outcomes and patient care worldwide. This dedicated news hub provides investors and healthcare professionals with timely updates on corporate developments, financial performance, and product advancements shaping the medical device sector.
Access authoritative information on CNMD's latest earnings reports, regulatory milestones, and strategic partnerships. Our curated collection includes press releases detailing new product launches in orthopedics, general surgery, and patient monitoring systems, along with updates on global market expansion initiatives.
Stay informed about critical developments through verified announcements directly from Conmed Corporation and third-party analysis. This resource enables stakeholders to track the company's progress in advancing minimally invasive surgical techniques and improving clinical workflows across healthcare institutions.
Bookmark this page for streamlined access to CNMD's evolving role in medical technology innovation. Regularly updated content supports informed analysis of the company's market position and long-term growth trajectory within the competitive healthcare solutions landscape.
CONMED Corporation (NYSE:CNMD) will announce its fourth-quarter 2021 financial results after market close on January 26, 2022. The company's management will host a conference call at 4:30 p.m. ET the same day to discuss these results. Interested participants can join the call via phone or webcast through CONMED's website. A recording will be available for a week following the call. The company focuses on surgical devices for minimally invasive procedures across various medical specialties.
CONMED Corporation (NYSE: CNMD) has declared a quarterly cash dividend of
CONMED Corporation (NYSE: CNMD) has announced its participation in the Piper Sandler 33rd Annual Virtual Healthcare Conference. The pre-recorded fireside chat featuring Chair and CEO Curt R. Hartman and CFO Todd W. Garner will be available from 10:00 a.m. ET on November 22 until December 2, 2021, for registered attendees. Additionally, the chat can be replayed on the Company’s website starting November 22 at 10 a.m. ET. CONMED specializes in surgical devices for minimally invasive procedures across various medical specialties.
CONMED Corporation (NYSE: CNMD) announced that
CONMED Corporation (NYSE: CNMD) has announced that Curt R. Hartman, Chair of the Board, President, and CEO, along with Todd W. Garner, Executive VP and CFO, will present at the Stifel 2021 Virtual Healthcare Conference on November 16, 2021, at 2:40 ET. Interested parties can access a live webcast through the Company’s website. CONMED specializes in providing innovative surgical devices for minimally invasive procedures across various medical specialties, including orthopedics and general surgery.
CONMED Corporation (NYSE: CNMD) reported a 4.6% year-over-year increase in sales for Q3 2021, totaling $248.8 million. Domestic sales rose 1.6%, while international sales grew by 8.5%. Diluted EPS was $0.47, up from $0.23 in Q3 2020. Adjusted diluted EPS decreased to $0.80 from $0.88. The company adjusted its full-year revenue guidance to $1.015 billion - $1.025 billion due to ongoing pandemic impacts. Full-year adjusted diluted EPS guidance is now $3.18-$3.23, slightly revised from $3.15-$3.25.
CONMED Corporation (NYSE: CNMD) will release its financial results for the third quarter of 2021 on October 27, 2021, after the market closes. A conference call to discuss these results is scheduled for 4:30 p.m. ET on the same day. Participants can join via phone or through a webcast available on CONMED's website. The call will be re-playable from 7:30 p.m. ET on the same day until 7:30 p.m. ET on November 3, 2021.
CONMED Corporation (NYSE: CNMD) announced that Curt R. Hartman, Chair and CEO, along with CFO Todd W. Garner, will participate in a virtual fireside chat at the 19th Annual Morgan Stanley Global Healthcare Conference on September 14, 2021, at 5:00 p.m. ET.
The session will be available for live viewing on the Company’s website, www.conmed.com, and can be replayed later.
CONMED specializes in surgical devices for minimally invasive procedures across various medical fields.
CONMED Corporation (NYSE: CNMD) has declared a quarterly cash dividend of $0.20 per share, payable on October 5, 2021, to shareholders of record as of September 15, 2021. This decision reflects the company’s commitment to returning value to shareholders amidst ongoing challenges, including those presented by the COVID-19 pandemic. CONMED specializes in medical technology, offering surgical devices for minimally invasive procedures across various medical fields.
CONMED Corporation (NYSE: CNMD) reported a strong financial performance for Q2 2021, with sales reaching $255.2 million, a 61.7% increase year over year. Domestic revenue surged 64.2%, while international sales climbed 58.6%. Diluted EPS was $0.41, up from a loss of $0.96 in Q2 2020. The company raised its full-year revenue guidance to between $1.015 billion and $1.035 billion and adjusted EPS guidance to $3.15 to $3.25, reflecting confidence in ongoing operational improvements and market recovery.
FAQ
What is the current stock price of Conmed (CNMD)?
What is the market cap of Conmed (CNMD)?
